GlaxoSmithKline (GSK) Says No Plan for ViiV Healthcare Spinoff "at the Moment"
1/10/2013 7:33:50 AM
More...
|
ViiV Healthcare Says Phase III Data From VIKING-3 Dolutegravir Study Encouraging
11/14/2012 7:19:13 AM
More...
|
Shionogi, Inc.-ViiV Healthcare to File HIV Drug dolutegravir for Approval
10/4/2012 7:27:29 AM
More...
|
ViiV Healthcare Expands Commitment to Addressing Gaps in Paediatric HIV Research, Care and Treatment
7/18/2012 11:43:25 AM
More...
|
Siemens Healthcare Diagnostics Forms New Companion Diagnostics Partnerships with ViiV Healthcare and Tocagen Inc.
2/8/2012 8:40:54 AM
More...
|
ViiV Healthcare's Positive Action for Children Fund Announces 16 New Grantees for the Year 2011/2012
10/13/2011 11:34:05 AM
More...
|
ViiV Healthcare Starts Phase III Clinical Programme of Celsentri/Selzentry® (maraviroc) Versus Truvada® (tenofovir + FTC), in Combination With a Protease Inhibitor in People Living With HIV
10/11/2011 12:03:07 PM
More...
|
ViiV Healthcare, Pfizer Inc. (PFE), GlaxoSmithKline (GSK) JV Denies Changing Discounts to AIDS Drugs
7/22/2011 7:20:08 AM
More...
|
Idenix Pharmaceuticals, Inc. (IDIX) Announces $20 Million Milestone Payment From ViiV Healthcare for Initiation of Phase IIb Trial of '761
11/23/2010 6:44:05 AM
More...
|